ריספפר 2 מ"ג Israel - hebreu - Ministry of Health

ריספפר 2 מ"ג

pharmalogic ltd - risperidone 2 mg - film coated tablets - risperidone - risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidone is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidone is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract

ריספפר 3 מ"ג Israel - hebreu - Ministry of Health

ריספפר 3 מ"ג

pharmalogic ltd - risperidone 3 mg - film coated tablets - risperidone - risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidone is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidone is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract

ריספפר 4 מ"ג Israel - hebreu - Ministry of Health

ריספפר 4 מ"ג

pharmalogic ltd - risperidone 4 mg - film coated tablets - risperidone - risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidone is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidone is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract

קומירנטי PBS Israel - hebreu - Ministry of Health

קומירנטי pbs

pfizer pharmaceuticals israel ltd - covid-19 mrna vaccine - covid-19 mrna vaccine 0.5 mg/ml - covid-19 vaccines

קימריה Israel - hebreu - Ministry of Health

קימריה

novartis israel ltd - tisagenlecleucel - tisagenlecleucel

טרקליר 62.5 מג Israel - hebreu - Ministry of Health

טרקליר 62.5 מג

j-c health care ltd - bosentan - טבליות מצופות פילם - bosentan 62.5 mg - bosentan - bosentan - treatment of pulmonary arterial hypertension (pah) in patients of who functional class ii-iv.reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease

טרקליר 125 מג Israel - hebreu - Ministry of Health

טרקליר 125 מג

j-c health care ltd - bosentan - טבליות מצופות פילם - bosentan 125 mg - bosentan - bosentan - treatment of pulmonary arterial hypertension (pah) in patients of who functional class ii-iv.reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease

קומירנטי 30 TRIS Israel - hebreu - Ministry of Health

קומירנטי 30 tris

pfizer pharmaceuticals israel ltd - covid-19 mrna vaccine - covid-19 mrna vaccine 0.5 mg/ml - covid-19 vaccines

קספליון 50 מג Israel - hebreu - Ministry of Health

קספליון 50 מג

j-c health care ltd - paliperidone as palmitate - תרחיף להזרקה - שחרור נרחב - paliperidone as palmitate 100 mg / 1 ml - paliperidone - paliperidone - xeplion is indicated for the acute and maintenance treatment of schizophrenia in adults.

קספליון 100 מג Israel - hebreu - Ministry of Health

קספליון 100 מג

j-c health care ltd - paliperidone as palmitate - תרחיף להזרקה - שחרור נרחב - paliperidone as palmitate 100 mg / 1 ml - paliperidone